Skip to main content

Terumo Blood and Cell Technologies

Unlocking the Potential of Blood As a global leader in blood component, therapeutic apheresis and cellular technologies, we believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers. Advancing Health Care Worldwide Working together with our customers, we can make safer, higher-quality transfusions available to more people. We can bring even more treatment options to patients through advanced blood therapies. And we can make the dream of new, cutting-edge blood and cell therapies the new standard of care. Our work has the potential to fundamentally improve health care. We are guided by our customers' needs, aspirations and ongoing drive to improve efficiency and patient outcomes. We Are a Terumo Group Company Terumo was founded in 1921 by a group of medical scientists led by Dr. Shibasaburo Kitasato, for the purpose of manufacturing reliable clinical thermometers in Japan. For over a century, Terumo has continued to contribute to society through healthcare. Today, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. Terumo will further strive to be of value to patients, medical professionals, and society at large.
Visit website